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Evidence is accumulating for naturally occuring humoral and cellular immu- 
nity against mouse C-type particles or mouse tumor cells. (1-9 and footnote 1). It 
has recently been shown in several systems that  cell-mediated immune  reac- 
tions, as measured by in vitro killer cell activity, occur naturally among rodents 
(2, 4, 8, 9,  10, and footnote 1). We have described the existence of natural killer 
(NK)  2 cells against  certain  mouse lymphomas,  notably of Moloney type  (10). 
This NK activity could be shown to be under polygenic control, with a major role 
being played by H-2 locus-associated gene (s) (11). A high degree of concordance 
was seen when  syngeneic or semisyngeneic mice of different genotypes were 
compared for in vitro NK activity and for in vivo resistance to Moloney lym- 
phoma cells (12).  In fact, there are reasons to believe that these NK cells may 
play one of the most important roles in the initial resistance against transplan- 
tation of syngeneic Moloney lymphomas in the mouse (13). 
This  NK activity seemed to be specific in the  sense that  only certain  lym- 
phoma target  cells were killed,  whereas others,  although highly sensitive for 
immune  T-cell  killing,  were unaffected.  When a  limited number of cell lines 
were studied the specificity seemed to be restricted to Moloney leukemia virus- 
induced lymphomas (10), but recent results show that also certain other types of 
tumors might be sensitive (unpublished results). 
Spleen cells from congenitally atyhmic nude mice have high NK activity (14) 
which  provided  the  first  indication  of a  non-T-cell  nature  of the  killer  cell. 
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Further strengthening its non-T-cell nature, the NK cell proved to be resistant 
to antitheta plus complement treatment.  However, it is not a B cell inasmuch as 
depletion of Ig-positive cells only served to enrich  for killer cell activity  (14). 
Thus, this cell lacks the surface characteristics of mature T or B lymphocytes. 
Still its low adherent properties as well as its morphology (14), make it highly 
probable  that  the  NK  cell  is  a  lymphocyte.  Furthermore,  preliminary  data 
suggest the NK cell to be distinct from the K  cells participating  in antibody- 
induced cell-mediated  (ADCC) reactions  (14).  In all,  the characteristics  of the 
NK cell seem very similar to those of the N cell described by Herberman et al. in 
another NK cell system (15). 
In the present article we have tried to further define the characteristics 'of the 
NK cells in comparison to two other previously defined killer cell systems. 
Materials  and Methods 
Mice.  1-2-too-old  CBA mice maintained by continuous single-line brother-sister mating in 
our laboratory were used. 
Tumors.  The YAC line was derived from a  Moloney virus-induced lymphoma in A/Sn mice 
and propagated  in ascites form.  An in vitro subline,  YAC-1,  adapted to stationary suspension 
culture (16) was maintained in medium F  13. 
Also the methylcholanthrene-induced P 815 mastocytoma of DBA/2 origin was used either as an 
in vitro line or propagated in the ascites form. 
Preparation of  Effector Cells.  Spleen cell suspensions were prepared in F 13 medium completed 
with 10% fetal calf serum and HEPES buffer (pH 7.3). 
Peripheral  blood  leukocytes  were  prepared  from  heparinized  whole  blood  using  a  Ficoll- 
Isopaque  gradient  (17).  In  some  experiments  adherent and phagocytic  cells  were  removed by 
carbonyl iron and magnet treatment (17). 
Immunization Procedure.  CBA mice were immunized once with 3  x  107 living P  815 ascites 
cells i.p. 9-12 days after immunization their spleen cells were used as source of immune anti-P 815 
cells. 
Cytotoxic Assays in the NK, P 815, and Chicken Red Blood Cell (CRBC) Systems.  A conven- 
tional 6 h  5~Cr release technique was used in the NK,  P  815, and CRBC systems, as previously 
described (14),  using triplicates. Experimental details like pretreatment of effector cells, incuba- 
tion  procedures,  and  incubation  time  was  always  identical  between  the  three  systems,  and 
experiments were always run in parallel. 
In the CRBC system a  mouse antichicken erythrocyte or a  normal mouse serum at a  104-fold 
dilution was added. Isotope release of the CRBC cells in the presence of medium alone was always 
identical to isotope release in the presence of normal mouse serum, and therefore these data are 
not shown.  In the P  815 system normal spleen cells were not included as controls, since in our 
hands this tumor has proved to be resistant to lysis by normal spleen cells (10). Isotope release is 
expressed as percent lysis according to the previously described formula (10). 
Erythrocyte Antibody Complement (EAC) Rosette Technique.  EAC rosettes were prepared and 
separated as previously described (17). 
Trypsin  Treatment of Effector Cells.  Spleen cells at a  concentration of 2-3  ×  107  ml  were 
treated with different concentrations (see figure legends) of trypsin  (State Bacteriological Co., 
Stockholm, Sweden) for 45 min at 37°C and thereafter washed twice in complete F 13 medium. 
Preparation of Aggregated Gamma Globulin.  Human or mouse IgG from normal serum was 
produced  by  standard  DEAE-cellulose  and  Sephadex  G-200 fractionation procedures.  IgG of a 
concentration of 10 mg/ml in phosphate-buffered saline, pH 7.4, was heat aggregated using 10-min 
incubation at 63°C. 
Nylon  Wool Column Passage.  Normal  or immune CBA spleen cells were passed through a 
nylon wool column according to a  modification (18) of the original method (19). 
Preparation and Use of  Antitheta Serum.  AKR anti-C3H antiserum was produced and used as 
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Results 
Separation of complement Receptor-Bearing Cells  with EAC Rosette  Tech- 
nique.  Most B cells, as well as cells of the monocytic series, carry C3b or C3d 
complement receptors (17). The EAC rosette fractionation technique is a  sensi- 
tive method for selective fractionation of these receptor-bearing cells. 
In our hands this technique gave a more complete separation and caused less 
nonspecific cell loss when peripheral blood was used instead of spleen as lympho- 
cyte source. Peripheral blood leukocytes are more active in the NK system than 
spleen cells and show the same genotype dependency. Like spleen cells, they are 
resistant to iron-magnet treatment and to treatment with antitheta serum and 
complement (results not shown here).  We thus conclude that the same NK cell 
was active in both of these cellular compartments. 
In four separate experiments using EAC rosette depletion techniques we could 
show that the  depleted cells were equally or somewhat more active than  the 
nonseparated cells in lysing the YAC cells (see example in Fig. 1 a). Thus a cell 
population without complement receptor-positive cells is highly efficient in the 
NK system. In contrast, but as expected (20),  EAC depletion strongly reduced 
the killer efficiency in the ADCC system (Fig.  1 b), which further supports the 
notion of the nonidentity of these two systems. 
Fractionation of Spleen Cells with the Nylon Wool Column Method and with 
Antitheta Serum Plus Complement.  The low adhesiveness of the NK cell has 
previously  been  shown  with  the  iron-magnet  method.  Also,  the  non-B-cell 
character of this cell type was suggested by the failure to be removed via passage 
of spleen cells through  an antimouse  Ig column,  which if anything  caused an 
increase of NK activity of the passed cells (14). In line with the results from both 
these methods the nylon wool column passage method, known to remove adher- 
ent cells and B cells (19), failed to diminish the NK activity of the passed spleen 
cells in any of four experiments performed. If cells sticking to nylon fibers were 
mechanically eluted by stirring with a  Pasteur pipette, these cells were clearly 
less efficient as killer cells against YAC-1 than nonpassed or passed cells (Fig. 2 
a). 
Similar  results  were obtained  in  the  P  815  immune  system,  where passed 
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FIG.  1.  Effect of EAC rosette depletion on the cytotoxicity in the NK (a) or CRBC system 
(b). EAC rosette-depleted  (O- O) or nondepleted (x -  x) peripheral blood leukocytes from 
normal CBA mice were used as effector cells. >- 
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FIG.  2.  Effect of  nylon wool column passage on the cytotoxicity in the NK  (a),  P 815 (b),  or 
the CRBC  system (c).  Passed (O  - O), nonpassed (  x - ×), or  eluted (A - A) normal (a  and c) 
or immune  (b) CBA  spleen cells  were used as effecter  cells. 
Contrariwise to the results  from these two systems the killer  efficiency  in the 
CRBC  system was always clearly,  if  not  totally,  decreased by passage (Fig.  2 c). 
The NK  cell  has been shown to be insensitive  to treatment with antitheta 
serum and complement. Furthermore, if antitheta serum treatment was fol- 
lowed by passage through an anti-Ig column,  this combined  fractionation 
method only served to enrich for killer  cell  activity  (14).  Similar experiments 
were now performed with a nylon column instead of an anti-lg column. Al- 
though the enrichment of  NK  activity  was not  as  pronounced with this  fraction- 
ation procedure, the remaining cells  were indeed highly cytotoxic  for  the YAC-1 
target cells  (Fig. 3 a). In contrast, after  treatment with antitheta serum and 
complement, the immune anti-P 815 activity  was totally  abrogated as expected 
(Fig. 3 b). 
These results  thus confirm that  the  dominant cell  population active  in  the  NK 
system is  low adherent and lacks  theta antigen  as  well as  surface immunoglobu- 
lin.  They do not  rule  out,  however, that  minor nonimmune cytolytic  effects  could 
be attributed to T cells,  B cells,  or monocytes. 
Killer Cell Activity after Addition of Aggregated Human or Mouse Gamma 
Globulin.  Fig.  4  illustrates the  effect of adding heat-aggregated human or 
mouse immunoglobulin to the NK, CRBC, or P 815 systems. The mouse immu- 
noglobulin was either prepared from normal serum of CBA mice (high reactive 
in the NK system) or ACA mice (low reactive in the NK system). No difference 
in the activity of  the immunoglobulin according to strain of  origin was observed. 
As expected, a pronounced inhibition in the CRBC system was seen with both 
the human and mouse preparations at dilutions down to 1/3125 (Fig. 4 c).  No 
significant inhibition was seen in the NK system (Fig. 4 a) or in the P 815 system 
(Fig. 4 b) even at the higher concentrations. This result thus strongly argues 
against the NK system to rely on killer cell mechanisms involving activation of 
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Fro.  3.  Effect of combined anti-~  +  complement treatment  followed by passage through 
nylon wool column on the cytotoxic effect in the NK system (a). As control the effect of anti- 
complement treatment in the immune P  815 system is shown (b).  Normal (a) or immune 
(b)  CBA spleen cells treated  with  normal  mouse serum and  complement  (x -  ><), anti-0 
serum plus complement (& -  &), or anti-0 serum plus complement followed by nylon wool 
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DILUTION  OF  AGGREGATED  q-GLOBULIN 
FIG.  4.  Effect of heat-aggregated gamma globulin on the cytotoxicity in the NK (a), P 815 
(b), or the CRBC system (c).  Percent lysis by normal (a and c) or immune  (b) CBA spleen 
cells  alone  at  an effector/target  cell  ratio  of 50/1  is  indicated  (- -  -).  Human  (x-  x)  or 
mouse gamma globulin from ACA (O-  O) or CBA (Z~- Z~) mice were used. In the undiluted 
preparation  (1/1) the concentration  of aggregated gamma  globulin was 160 mg/ml for the 
human  and 20 mg/ml for the mouse in the final incubation mixture. 
Trypsin  Treatment of Effector  Cells.  Proteolytic enzymes digest most cell 
surface receptors, except for Fc receptors (21)• Therefore pretreatment ofeffector 
cells  with  trypsin  might  distinguish  Fc receptor dependent  from  Fc receptor 
independent  immune  reactions.  In  a  series  of experiments  the  resistance  of 
spleen cells to pretreatment with trypsin at various concentrations was investi- 
gated.  After trypsin treatment  spleen cells were tested simultaneously in the 
NK, CRBC, and the immune P  815 systems. The results from one such repre- 
sentative parallel experiment is illustrated in Fig. 5. As shown earlier by others 
(22),  the  effector cell  in  the  ADCC  system  was  relatively  trypsin  resistant, 
although a slight decrease in killing activity started to appear at a concentration 777 
80, 





o  b 
80,  80. 





KIESSLING,  PETRANYI,  KARRE,  JONDAL,  TRACEY,  AND  WIGZELL 
j~  2~ 
,  L  0  A"""  0  t,J 
50If  25/I  12.5/l  50If  25/f  12.5/l  25'/'  12.5'/I  1.25/l 
EFFECTOR:  TARGET  CELL  RATfO 
FIG.  5.  Effect ofpretreatment with trypsin on the cytotoxicity in the NK (5a), P 815 (b), or 
CRBC (c) system.  Normal  (a and c) or immune  (b) CBA spleen cells pretreated with 1% 
(© -  G), 0.25% (A _ A), 0.001% (D -  [3), or trypsin buffer alone ( × -  x ) were used as effector 
cells. 
of 0.25% trypsin, being still more marked at 1% (Fig. 5 c). When the same spleen 
cells were tested for NK activity against YAC-1 cells a strong reduction already 
at 0.25% trypsin concentration was noted (Fig. 5 a). This reduction was compa- 
rable to the effect after similar treatment of immune spleen cells in the P  815 
system (Fig.  5 b).  Low trypsin concentrations (0.001%) did not markedly affect 
any of the  three  systems  (Fig.  5).  Thus,  both  NK  cells  and  CTL were  quite 
sensitive to trypsin treatment in comparison to the effector cell system involved 
in ADCC reactions. 
Discussion 
In cell-mediated immune responses to allografts and tumors cytolytic thymus- 
derived lymphocytes are known to play an important role (for references see 23). 
In contrast to this,  we and others have previously shown that nonimmune,  so 
called, NK cells are insensitive (14) or almost insensitive (15) to antitheta serum 
treatment. These data and the fact that nude spleen cells are highly efficient as 
killer  cells  would  argue  against  this  cell  type  being  a  mature  T  cell.  The 
possibility that the NK might be a precursor T cell not expressing Thy-1 antigen 
has,  however, been considered by us.  Pretreatment of normal or nude mice in 
vivo or in vitro with various nonthymic (polyadenylic-uridylic acid, lipopolysac- 
charide) or thymic agents, by others reported to induce theta positiveness in T- 
precursor cells (24), has so far not rendered the NK cell sensitive to antitheta 
treatment.  We are now continuing this search for a  surface marker on the NK 
cell, also using various antisera directed against differentiation antigens on the 
precursor T  cells. 
NK cells have previously been found to lack detectable surface Ig (14, 15), and 
in the present article they could be shown also to lack receptors for C3 compo- 
nents.  Similar results  were seen by others  using  EAC  monolayer absorption 778  NATURAL  KILLER  CELLS  COMPARED  TO  CTL  AND  ADCC 
(15). Contrariwise, similar treatment would cause an almost total abrogation of 
killer activity in the ADCC system. 
In  the  present  article  we  also tried  to further  analyze  the  means  through 
which NK cells do exert their cytolytic activity. We could confirm the results of 
others (most likely studying the very same cell type [15]) that aggregated IgG, 
while completley abrogating the cytotoxicity in ADCC displayed no detectable 
impact  on the  NK activity.  These data strongly argue  against  any cytophilic 
antibody  being  present  on the  NK  cells  and  thereby  inducing  these  cells to 
become killer cells. 
We have previously found the  NK cells to be nonadherent  as measured by 
carbonyl  iron  and  magnet  and/or  passage  through  glass  bead  columns  (14). 
Other workers have reported similar findings (15). In the present article we now 
report on further work using nylon fiber columns known to be highly efficient in 
the removal of adherent cells (19).  Both adherent and nonadherent  cells were 
tested for their capacity to function as NK cells. Again,  the nonadherent  cells 
contained excellent activity, whereas the adherent,  eluted cells displayed con- 
siderably  weaker  NK  function.  We  would  thus  conclude  that  under  three 
varying conditions, each of which are known to remove adherent cells, NK cells 
failed to adhere to any significant degree. 
The trypsin sensitivity of the NK activity was also analyzed in parallel to the 
ADCC and the CTL systems. Here, it was found that both NK and T-killer cells 
were quite trypsin sensitive, whereas the ADCC effector cells were relatively 
trypsin resistant.  This would fit nicely with earlier reports on the Fc receptor 
involved in ADCC to be trypsin resistant (2.2) and would then further dissociate 
the NK cell from the K  cell in the ADCC systems. However, Herberman et al. 
found the NK cell to be trypsin resistant (15). This discrepancy with our results 
could  probably  be  explained  by their  use  of a  considerably  shorter  trypsin 
preincubation period (20 min compared to 45 min). 
We are then left with somewhat of a  dilemma.  The NK cells look like small 
lymphocytes  (the  population  left  from  mouse  spleen  cells  after  removal  of 
adherent cells and T and B lymphocytes is to more than 95% small lymphocytes 
and contain virtually all NK activity [14]). Yet, no surface marker characteris- 
tic of either T or B lymphocytes or of monocytes has been found on the NK cell 
surface.  Furthermore,  the  NK  cells  express  cytotoxic  activity  with  specific 
direction  analogous to conventional  immune  reactions  indicating  an "inborn" 
reactivity carried out by products of the NK cell itself. However, it still remains 
to determine the nature of those structures on NK cells which endow these cells 
with their immune (or immune-'like") specificity. Such a search would however 
seem very worthwhile as the present NK activity seems to represent  a  major 
(maybe the major) barrier in the resistance towards certain syngeneic or semi- 
syngeneic virus-induced lymphomas in the mouse (13). 
Summary 
Previous reports have shown that spleen cells from nonimmune adult mice of 
certain strains do regularly kill Moloney leukemia virus-induced lymphomas in 
short-term 5'Cr release assays. This naturally occuring killer (NK) cell had low 
adherent  properties  and  had  the  morphological  appearance  of a  lymphocyte. 
Still it lacked surface characteristics of mature T or B lymphocytes. KIESSLING,  PETRANYI,  K~RRE,  JONDAL,  TRACEY, AND  WIGZELL  779 
In the present report a functional study was carried out, comparing in parallel 
the  NK  system,  the T-cell killing  across  an H-2  barrier  (anti-PSi5),  and  the 
antibody-dependent  cell-mediated  chicken  red  blood  cell  (CRBC)  system.  In 
contrast to the effector cells in the CRBC system, the NK cells were insensitive 
to erythrocyte antibody complement  (EAC)  rosette depletion and  would pass 
through nylon wool columns. NK activity was not inhibited by the presence of 
heat-aggregated  human  or mouse gamma  globulin,  in  contrast to the  strong 
inhibition noted in the CRBC system.  Sensitivity to trypsin pretreatment was 
noted in the  NK system as well as in the immune P815 system,  whereas  the 
CRBC  system  was  relatively  trypsin  resistant.  Antitheta  plus  complement 
eliminated  the  anti-P815  activity,  but  did  not  touch  the  NK  activity.  The 
present results thus further distinguish  the NK cell from cytotexic T  lympho- 
cytes or from antibody-dependent killer cells. 
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